Evidence map›Paper›PMID 41350472›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Exploring the feasibility of a 40-minute uptake time for long axial field of view [

Yibo He, Huaping Gao, Haojun Yu, Florent L Besson, Lorenzo Nardo, Yu Lin, Akram Al-Ibraheem, Hubing Wu, Wei Fan, Mike Sathekge and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yibo He *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Huaping Gao *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Haojun YuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Florent L BessonDepartment of Nuclear Medicine-Molecular Imaging, DMU Smart Imaging, Commissariat À L'énergie Atomique Et Aux Énergies Alternatives (CEA), Hôpitaux Universitaires Paris-Saclay, AP-HP, CHU Bicêtre, Université Paris-Saclay, Centre National de La Recherche Scientifique (CNRS), InsermBioMaps, Paris, Orsay, France.
Lorenzo NardoDepartment of Radiology, University of California Davis, Sacramento, CA, 95819, USA.
Yu LinDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Akram Al-IbraheemDepartment of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al- Jubeiha, Amman, 11941, Jordan.
Hubing WuNanfang PET Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, P.R. China.
Wei FanDepartment of Nuclear Medicine, Sun Yat-Sen University Cancer Center, No. 651 Dongfengdong Road, Guangzhou, 510060, P.R. China.
Mike SathekgeDepartment of Nuclear Medicine, University of Pretoria, Pretoria, 0001, South Africa.
Xinming ZhaoDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei Province, P.R. China.
Jiefu ZhengDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Medical Imaging, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA, 22908-0170, USA.
Axel RomingerDepartment of Nuclear Medicine, Bern University Hospital, Inselspital, University of Bern, Freiburgstrasse 18, Bern, CH-3010, Switzerland.
Denis AgostiniDepartment of Nuclear Medicine, University Hospital of Caen and Normandie Université, Caen, 4650, EA, France.
Wenxin TangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Runjun YangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yiqiu ZhangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Pengcheng HuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Ruimin WangDepartment of Nuclear Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, P.R. China.
Baixuan XuDepartment of Nuclear Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, P.R. China.
Zhi YangKey Laboratory of Carcinogenesis and Translational Research, (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Peking University Cancer Hospital & Institute, Beijing, 100142, P.R. China.
Yunze XieDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. shi.hongcheng@zs-hospital.sh.cn.ORCID 0000-0001-7457-876X

Funding

National High-End Medical Equipment Popularization and Application Program 2024TGYY06the Chinese National Key Clinical Specialty Program YWP2022-007the Innovative Medical Device Application Demonstration Program of Shanghai Municipal Commission of Economy and Informatization 23SHS01200the Key Program of Ministry of Industry and Information Technology of China CEIEC-2022-ZM02-0219
6 · The paper itself

Abstract

purposeThe EANM/SNMMI guidelines recommend an uptake time of 60 min for 2-[

methodsForty-three oncological patients who underwent 60-min total-body dynamic [

resultsThe activity curves reveal that the average LBRs gradually increased with time, with no significant difference between G

conclusionReducing the uptake time from 60 min to 40 min after [

Indexed as

Fluorodeoxyglucose F18NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overBiological TransportEvidence-Based MedicineFeasibility StudiesFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals2-[18F]fluoro-2-deoxy-D-glucosePositron emission tomography/Computed tomographyTime intervalTotal body

Identifiers

PMID41350472

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.